BenjaminYoungMDPhD, FIDSA(He/Him)

PubMed

• 4 citations
  Treatment challenges and health conditions among people living with HIV with or without substance use disorder in the Russian Federation
  Sergey Kuznetsov, Anton Eremin, Elena Zaytseva, Benjamin Young, Anna Basova, Alistair Paice, Omar Marin, Patricia de los Rios, Chinyere Okoli> ;AIDS Care. 2021 Aug 9
• 66 citations
  Undetectable equals untransmittable (U = U): awareness and associations with health outcomes among people living with HIV in 25 countries.
  Chinyere Okoli, Nicolas Van de Velde, Bruce Richman, Brent Allan, Erika Castellanos, Benjamin Young, Garry Brough, Anton Eremin, Giulio Maria Corbelli, Marta Mc Britto...> ;Sexually Transmitted Infections. 2021 Feb 1
• 65 citations
  Expert consensus statement on the science of HIV in the context of criminal law.
  Françoise Barré-Sinoussi, Salim S. Abdool Karim, Jan Albert, Linda-Gail Bekker, Chris Beyrer, Pedro Cahn, Alexandra Calmy, Beatriz Grinsztejn, Andrew E. Grulich, Adeeb...> ;Journal of the International AIDS Society. 2018 Jul 1
• 32 citations
  Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96...
  Onyema Ogbuagu, Peter Ruane, Daniel Podzamczer, Laura C Salazar, Keith Henry, David M Asmuth, David A. Wohl, Richard Gilson, Yongwu Shao, Ramin Ebrahimi, Stephanie Cox...> ;The Lancet. HIV. 2021 Jul 1
• 18 citations
  Shared Decision Making Between Patients and Healthcare Providers and its Association with Favorable Health Outcomes Among People Living with HIV.
  Chinyere Okoli, Garry Brough, Brent Allan, Erika Castellanos, Benjamin Young, Anton Eremin, Giulio Maria Corbelli, Marta Mc Britton, Marvelous Muchenje, Nicolas Van de...> ;AIDS and Behavior. 2021 May 1
• Risk Factors and Incidence of Syphilis in Human Immunodeficiency Virus (HIV)-Infected Persons: The HIV Outpatient Study, 1999-2015.
  Novak RM, Ghanem A, Hart R, Ward D, Armon C, Buchacz K, HIV Outpatient Study Investigators> ;Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
• 8 citations
  Report from the International Conference on Viral Hepatitis - 2017
  Vicente Soriano, Benjamin Young, Nancy Reau> ;AIDS Reviews. 2018 Jan 1
• 2 citations
  Report from the International Conference on Viral Hepatitis (ICVH), San Francisco, March 2016.
  Vicente Soriano, Benjamin Young, Norah A. Terrault> ;AIDS Reviews. 2016 Apr 1
• 22 citations
  Do people with HIV infection have a higher risk of fracture compared with those without HIV infection
  Jennifer F Hoy, Benjamin Young> ;Current Opinion in HIV and AIDS. 2016 May 1
• The Vancouver Consensus: antiretroviral medicines, medical evidence, and political will.
  Beyrer C, Birx DL, Bekker LG, Barré-Sinoussi F, Cahn P, Dybul MR, Eholié SP, Kavanagh MM, Katabira ET, Lundgren JD, Mworeko L, Pala M, Puttanakit T, Ryan O, Sidibé M, ...> ;Lancet (London, England).
• 50 citations
  The HIV care continuum in Latin America: challenges and opportunities.
  Alicia Piñeirúa, Juan Sierra-Madero, Pedro Cahn, Rafael Napoleón Guevara Palmero, Ernesto Martínez Buitrago, Benjamin Young, Carlos del Rio> ;The Lancet. Infectious Diseases. 2015 Jul 1
• Disparities in Initiation of Combination Antiretroviral Treatment and in Virologic Suppression Among Patients in the HIV Outpatient Study, 2000-2013.
  Novak RM, Hart RL, Chmiel JS, Brooks JT, Buchacz K, HIV Outpatient Study (HOPS) Investigators> ;Journal of acquired immune deficiency syndromes (1999).
• 10 citations
  Controlling the HIV Epidemic With Antiretrovirals: Moving From Consensus to Implementation
  Benjamin Young, José M. Zuniga, Julio S. G. Montaner, Kenneth H. Mayer> ;Clinical Infectious Diseases. 2014 Jul 1
• Sexual risk behavior and viremia among men who have sex with men in the HIV Outpatient Study, United States, 2007-2010.
  Durham MD, Buchacz K, Richardson J, Yang D, Wood K, Yangco B, Brooks JT, HOPS Investigators> ;Journal of acquired immune deficiency syndromes (1999).
• Provider compliance with guidelines for management of cardiovascular risk in HIV-infected patients.
  Lichtenstein KA, Armon C, Buchacz K, Chmiel JS, Buckner K, Tedaldi E, Wood K, Holmberg SD, Brooks JT, HOPS Investigators> ;Preventing chronic disease.
• Increased mortality among publicly insured participants in the HIV Outpatient Study despite HAART treatment.
  Palella FJ, Baker RK, Buchacz K, Chmiel JS, Tedaldi EM, Novak RM, Durham MD, Brooks JT, HOPS Investigators> ;AIDS (London, England).
• Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study.
  Lichtenstein KA, Armon C, Buchacz K, Chmiel JS, Buckner K, Tedaldi EM, Wood K, Holmberg SD, Brooks JT, HIV Outpatient Study (HOPS) Investigators> ;Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
• AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study.
  Buchacz K, Baker RK, Palella FJ, Chmiel JS, Lichtenstein KA, Novak RM, Wood KC, Brooks JT, HOPS Investigators> ;AIDS (London, England).
• 16 citations
  Acute onset insomnia associated with the initiation of raltegravir: a report of two cases and literature review
  Jacob Gray, Benjamin Young> ;AIDS Patient Care and Stds. 2009 Sep 9
• The association of HIV susceptibility testing with survival among HIV-infected patients receiving antiretroviral therapy: a cohort study.
  Palella FJ, Armon C, Buchacz K, Cole SR, Chmiel JS, Novak RM, Wood K, Moorman AC, Brooks JT, HOPS (HIV Outpatient Study) Investigators> ;Annals of internal medicine.
• Initiation of HAART at higher CD4 cell counts is associated with a lower frequency of antiretroviral drug resistance mutations at virologic failure.
  Uy J, Armon C, Buchacz K, Wood K, Brooks JT, HOPS Investigators> ;Journal of acquired immune deficiency syndromes (1999).
• 69 citations
  Kidney Disease in Patients with HIV Infection and AIDS
  Jonathan A. Winston, Gilbert Deray, Trevor Hawkins, Lynda A. Szczech, Christina M. Wyatt, Benjamin Young, Kenneth H. Mayer> ;Clinical Infectious Diseases. 2008 Dec 1
• Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994-2005.
  Buchacz K, Baker RK, Moorman AC, Richardson JT, Wood KC, Holmberg SD, Brooks JT, HIV Outpatient Study (HOPS) Investigators> ;AIDS (London, England).
• 271 citations
  The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 wee...
  Joseph J. Eron, Patrick Yeni, Joseph C. Gathe, Vicente Estrada, Edwin DeJesus, Schlomo Staszewski, Philip Lackey, Christine Katlama, Benjamin Young, Linda Yau, Denise ...> ;Lancet. 2006 Aug 5
• 2 citations
  PA update: DHHS guidelines for the treatment of HIV infection.
  Young B, Carmichael Jk, Denise H. Johnson, Mills T> ;JAAPA. 2006 Jan 1
• Join now to see all

Journal Articles

• Viewing changes in the HIV care cascade over time  
  EM Gardner, B Young, Lancet Infect Dis, 9/26/2013
• Provider Guidance for Linking Patients to Antiretroviral Therapy Adherence Interventions: Recommendations from an IAPAC Advisory Committee on Adherence Monitoring and ...  
  KR Amico, JM Zuniga, I Wilson, R Gross, B Young, J Int Assoc Providers AIDS Care, 3/1/2013
• Achieving Improvements across the Treatment Cascade: A Clinical Management Algorithm Based on IAPAC’s Entry into and Retention in Care and Antiretroviral Therapy Adher...  
  J Zuniga and B Young, J Int Assoc Providers AIDS Care, 1/1/2013
• Immune Reconstitution Inflammatory Syndrome (IRIS) in the HIV Outpatient Study (HOPS): Incidence and Implications for Mortality  
  RM Novak, JT Richardson, K Buchacz, JS Chmiel, MD Durham, FJ Palella, A Wendrow, K Wood, B Young, JT Brooks and the HOPS Investigators, AIDS, 3/27/2012
• Rapid and sustained antiviral response with once-daily dolutegravir in combination therapy in antiretroviral-naive adults: planned interim 48-week results from SPRING-...  
  J van Lunzen, F Maggiolo, JR Arribas, A Rakhmanova, P Yeni, B Young, JK Rockstroh, S Almond, I Song, C Bothers, S Min, Lancet Infect Dis, 2/1/2012
• Trends in Decline of Antiretroviral Resistance among ARV-experienced Patients in the HIV Outpatient Study (HOPS): 1999-2008  
  K. Buchacz, DJ Ward, RK Baker, F Palella, JS Chmiel, B Young, BG Yangco, R. Novak and J. Brooks, AIDS Res Treat, 1/1/2012
• QDMRK investigators Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomized, active-controlled, phase 3 non-inferiority trial  
  JJ Eron, JK Rockstroh, J Reynes, J Andrade-Villanueva, JV Ramalho-Madruga, L-G Bekker, B Young, C Katlama, JM Gatell-Artigas, JR Arrivas, M Nelson, H Campbell, J Zhao..., Lancet Infect Dis, 12/1/2011
• Higher and Increasing Rates of Fracture among HIV-infected Persons in the HIV Outpatient Study (HOPS) Compared to the General US Population, 1994-2008  
  B Young, C Dao, K Buchacz, R Baker, JT Brooks, Clin Infect Dis, 4/1/2011
• Transmission of integrase strand-transfer inhibitor, multi-drug resistant HIV-1: Case report and natural history of response to raltegravir-containing antiretroviral t...  
  B Young, S Fransen, KS Greenberg, A Thomas, S Martens, M St Clair, CJ Petropoulos, B Ha, Antivir Ther, 1/1/2011
• 96-Week Results of a Pilot Study of Abacavir/Lamivudine and Raltegravir in Antiretroviral-Naïve HIV-1 Infected Patients: the SHIELD Trial  
  B. Young, T. Vanig, E. DeJesus, T. Hawkins, M. St. Clair, B. Stancil, B. Ha, and the SHIELD study team, HIV Clin Trials, 1/1/2011
• Adherence to antiretroviral therapy in an urban, free-care HIV clinic in Guatemala City, Guatemala  
  Campbell JL, Ruano AL, Samayoa, B, Estrada Muy DL, Arathoon E, Young B, J Int Assoc Physicians AIDS Care, 11/12/2010
• Similar efficacy and tolerability of atazanavir (ATV) compared to atazanavir/ritonavir (ATV/RTV, r), each with abacavir/lamivudine (ABC/3TC) after initial suppression ...  
  Squires KE, Young B, DeJesus E, Bellos N, Murphy D, Sutherland-Phillips DH, Zhao HH, Patel LG, Ross LL, Wannamaker PG, Shaefer, MS for the ARIES study team, AIDS, 8/24/2010
• Changes in the Use of HIV Antiretroviral Resistance Testing in a Large Cohort of US Patients, 1999 to 2006  
  Buchacz K, Baker RK, Young B, Brooks JT; the HIV Outpatient Study (HOPS) Investigators, J Acquir Immune Defic Syndr, 4/1/2010
• Safety and efficacy of a 36-week induction regimen of abacavir/lamivudine and ritonavir-boosted atazanavir in HIV-infected patients  
  Squires KE, Young B, Dejesus E, Bellos N, Murphy D, Sutherland-Phillips DH, Zhao HH, Patel LG, Ross LL, Wannamaker PG, Shaefer MS, ARIES Study Team, HIV Clin Trials, 3/1/2010
• Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 ...  
  Eron JJ, Young B, Cooper DA, Youle M, Dejesus E, Andrade-Villanueva J, Workman C, Zajdenverg R, Fatkenheuer G, Berger DS, Kumar PN, Rodgers AJ, Shaughnessy MA, Walker ..., Lancet, 1/30/2010
• A Pilot Study of Abacavir/Lamivudine and Raltegravir in Antiretroviral-Naïve HIV-1 Infected Patients: 48-Week Results of the SHIELD Trial  
  B. Young, T. Vanig, E. DeJesus, T. Hawkins, M. St. Clair, L. Yau, B. Ha, and the SHIELD study team, HIV Clinical Trials, 1/1/2010
• Similar virologic and immunologic efficacy with fosamprenavir boosted with 100 mg or 200 mg of ritonavir in HIV-infected patients: results of the LESS Trial  
  C Cohen, E Dejesus, A Lamarca, B Young, L Yau, L Patel, C Vavro, MB Wire, P Wannamaker, M Schaefer, HIV Clinical Trials, 1/1/2010
• Acute onset insomnia associated with the initiation of raltegravir: a report of two cases and literature review  
  J Gray, B Young, AIDS Patient Care and STDs, 9/1/2009
• Renal function in patients with pre-existing renal disease receiving tenofovir-containing HAART in the HIV Outpatient Study (HOPS) cohort  
  B Young, K Buchacz, RK Baker, A Moorman, JS Chmiel, KC Wood, JT Brooks for the HOPS Investigators, AIDS Patient Care STDS, 8/1/2009
• Simplification of Antiretroviral Therapy (ART) with Efavirenz (EFV)/Emtricitabine (FTC)/Tenofovir DF (TDF) Single-Tablet-Regimen vs Continued Unmodified ART in Virolog...  
  E DeJesus, B Young, JO Morales Ramirez, L Sloan, DJ Ward, JF Flaherty, R Ebrahimi, J-F Maa , K Reilly, J Ecker, D McColl, D Seekins, JA Farajallah, J Acquir Immune Defic Syndr, 6/1/2009
• Utilization of screening colonoscopy in ambulatory HIV-infected patients  
  J Campbell, B Young, J Int Assoc Physicians AIDS Care, 12/1/2008
• The Prevalence of Transmitted Antiretroviral Drug Resistance in Treatment Naïve Patients and Factors Influencing First-Line Treatment Regimen Selection  
  HY Huang, ES Daar, P Sax, B Young, P Cook, P Benson, C Cohen, A Schribner, H Hu, HIV Medicine, 1/1/2008
• First large, multicenter, open-label study utilizing HLA-B*5701 screening for abacavir hypersensitivity in North America  
  B Young, K Squires, P Patel, E DeJesus, N Bellos, D Berger, DH Sutherland Phillips, Q Liao, M Shaefer, P Wananmaker, AIDS, 1/1/2008
• Kidney disease in patients with HIV infection and AIDS  
  J Winston, G Deray, T Hawkins, L Szczech, C Wyatt and B Young, Clin Infect Dis, 1/1/2008
• Renal function in tenofovir–exposed and –unexposed patients receiving highly active antiretroviral therapy (HAART) in the HIV Outpatient Study (HOPS) cohort  
  B Young, K Buchacz, RK Baker, A Moorman, JS Chmiel, KC Wood, JT Brooks for the HOPS Investigators, J Int Assoc Physicians AIDS Care, 1/1/2007
• Join now to see all